in Biochemistry and Molecular Biology from Johns Hopkins University, Pendulum was founded in 2012 by a diverse team of scientists with deep microbiology, biochemistry, computational and clinical expertise
Common reasons include: (1) Not yet on formulary new drugs take time to add, (2) Non-preferred tier requires additional PA or higher cost, (3) Step therapy insurer may require trying injectable first, (4) Administrative delays policies still being finalized
It also completely reshaped the way I understand nutrition, both personally and professionally
Prescription grade health care, from anywhere
Dr Armstrong said, These data represent an impressive degree of durability for bimekizumab, and they give us the confidence that bimekizumab can provide long-term disease control. #PsO #Dermatology Watch the full interview with Dr Armstrong at the link below